Enanta Pharma (ENTA) Tops Q2 EPS by 10c

Enanta Pharma (NASDAQ: ENTA) reported Q2 EPS of ($0.28), $0.10 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $8.96 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
• RH (RH) Tops Q2 EPS by $2.31